DEBORAH DONNELLY: Open Payments
NPI 1396894473 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 30 payments from 15 companies in 2025. Trend: 2023 $674 · 2024 $723 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Travere Therapeutics, Inc. | 3 | $67 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| Ardelyx, Inc. | 2 | $51 |
| Calliditas Therapeutics US Inc. | 2 | $51 |
| Vifor Pharma, Inc. | 2 | $43 |
| AKEBIA THERAPEUTICS INC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: Ozempic, JYNARQUE, ACTHAR, FARXIGA, IBSRELA, TARPEYO, Veltassa, Vafseo.
Industry payments across GA — which companies pay providers there.
